{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:37:37Z","timestamp":1787319457448,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004702","name":"University of Genoa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.freeradbiomed.2016.07.031","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T20:56:41Z","timestamp":1469912201000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells"],"prefix":"10.1016","volume":"99","author":[{"given":"G.","family":"Muzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Traverso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Monacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Oraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maggiora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Canuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2014.01.020","article-title":"Clinically relevant determinants of body composition, function and nutritional status as mortality predictors in lung cancer patients","volume":"84","author":"Kovarik","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3148\/74.2.2013.69","article-title":"Sarcopenia and physical function in overweight patients with advanced cancer","volume":"4","author":"Prado","year":"2013","journal-title":"Can. J. Diet. Pract. Res."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1017\/S0007114512004527","article-title":"Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frame-works","volume":"109","author":"van der Meij","year":"2013","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: mechanisms and potential targets for intervention","volume":"22","author":"Argil\u00e9s","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib7","doi-asserted-by":"crossref","first-page":"168407","DOI":"10.1155\/2014\/168407","article-title":"Inflammation based regulation of cancer cachexia","volume":"2014","author":"Onesti","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib8","doi-asserted-by":"crossref","first-page":"820934","DOI":"10.1155\/2015\/820934","article-title":"Potential biomarkers of fat loss as a feature of cancer cachexia","volume":"2015","author":"Ebadi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib9","unstructured":"L. Radbruch, F. Elsner, P. Trottenberg, F. Strasser, K. Fearon, Clinical practice guidelines on cancer cachexia in advanced cancer patients with a focus on refractory cachexia, European Clinical Guidelines, Aachen, 2010."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MEG.0b013e3280bdc093","article-title":"Should patients with cancer be offered nutritional support: does the benefit outweigh the burden?","volume":"19","author":"Koretz","year":"2007","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/sj.bjc.6600659","article-title":"Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation","volume":"87","author":"Pratt","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/bjc.1991.481","article-title":"Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease","volume":"64","author":"Chaudry","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clnu.2009.11.006","article-title":"Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients","volume":"29","author":"Murphy","year":"2010","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11745-011-3641-2","article-title":"Aberrations in plasma phospholipid fatty acids in lung cancer patients","volume":"47","author":"Murphy","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3835(94)90126-0","article-title":"Interleukin-6 does not activate protein breakdown in rat skeletal muscle","volume":"76","author":"Garc\u00eda-Mart\u00ednez","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2004.08.196","article-title":"Suppression of cancer cachexia by 20S,21-epoxy-resibufogenin-3-acetate-a novel nonpeptide IL-6 receptor antagonist","volume":"323","author":"Enomoto","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2407-7-45","article-title":"Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer","volume":"7","author":"Zhang","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1017\/S0029665112000067","article-title":"Long-chain fatty acids and inflammation","volume":"71","author":"Calder","year":"2012","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0269216311418709","article-title":"Systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project","volume":"26","author":"Ries","year":"2012","journal-title":"Palliat. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.bjc.6601132","article-title":"Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolisis-inducing factor (PIF) is associated with activation of the transcription factor NF-kB","volume":"89","author":"Whitehouse","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.plefa.2005.03.002","article-title":"Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia, Prostaglandins Leukot","volume":"72","author":"Russell","year":"2005","journal-title":"Essent. Fatty Acids"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3945\/ajcn.110.005611","article-title":"Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial","volume":"93","author":"Smith","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1139\/H07-087","article-title":"Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome","volume":"32","author":"Robinson","year":"2007","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2010.03.015","article-title":"Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE","volume":"49","author":"Long","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1471-4159.2007.05175.x","article-title":"Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation","volume":"105","author":"Long","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1432-1033.2004.04042.x","article-title":"Induction of endothelial apoptosis by 4-hydroxyhexenal","volume":"271","author":"Lee","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2004.08.023","article-title":"Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells","volume":"204","author":"Choudhary","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib28","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1093\/ndt\/gfr386","article-title":"4-Hydroxy-2-hexenal-induced apoptosis in human renal proximal tubular epithelial cells","volume":"26","author":"Bae","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cbi.2010.06.015","article-title":"Quantitative structure-activity relationship for 4-hydroxy-2-alkenal induced cytotoxicity in L6 muscle cells","volume":"188","author":"Pillon","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.neurobiolaging.2010.08.016","article-title":"Elevated 4-hydroxyhexenal in Alzheimer\u2019s disease (AD) progression","volume":"33","author":"Bradley","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jprot.2013.06.004","article-title":"Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms?","volume":"92","author":"Domingues","year":"2013","journal-title":"J. Proteom."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/bbrc.2000.2691","article-title":"4-Hydroxynonenal-induced MEL cell differentiation involves PKC activity translocation","volume":"272","author":"Rinaldi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0006-291X(02)00649-6","article-title":"4-Hydroxynonenal affects pRb\/E2F pathway in HL-60 human leukemic cells","volume":"295","author":"Barrera","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.freeradbiomed.2008.10.035","article-title":"MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation","volume":"46","author":"Pizzimenti","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/867915","article-title":"Decreased polyunsaturated fatty acid content contributes to increased survival in human colon cancer","author":"Oraldi","year":"2009","journal-title":"J. Oncol."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib36","first-page":"441","article-title":"Lactic dehydrogenase of muscle","volume":"vol.1","author":"Kornberg","year":"1955"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/excr.1995.1104","article-title":"Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression","volume":"217","author":"Barbiero","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cbi.2011.01.011","article-title":"Importance of inverse correlation between ALDH3A1 and PPAR\u03b3 in tumour cells and tissue regeneration","volume":"191","author":"Oraldi","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/clinchem\/43.7.1209","article-title":"Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors","volume":"43","author":"Nielsen","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib40","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1021\/ja00401a020","article-title":"Degenerative chemistry of malondialdehyde. Structure, stereochemistry, and kinetics of formation of enaminals from reaction with amino acids","volume":"103","author":"Nair","year":"1981","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.redox.2013.04.001","article-title":"Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease","volume":"1","author":"Chapple","year":"2013","journal-title":"Redox Biol."},{"issue":"5 Suppl","key":"10.1016\/j.freeradbiomed.2016.07.031_bib42","doi-asserted-by":"crossref","first-page":"779S","DOI":"10.1093\/ajcn\/57.5.779S","article-title":"Cytotoxicity and genotoxicity of lipid-oxidation products","volume":"57","author":"Esterbauer","year":"1993","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.freeradbiomed.2009.05.032","article-title":"Lipid peroxidation: physiological levels and dual biological effects","volume":"47","author":"Niki","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/carcin\/22.5.701","article-title":"Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells","volume":"22","author":"Hughes-Fulford","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib45","first-page":"712536","article-title":"The janus face of lipids in human breast cancer: how polyunsaturated Fatty acids affect tumor cell hallmarks, Int","volume":"2012","author":"Ch\u00e9nais","year":"2012","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jnutbio.2012.06.005","article-title":"High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation","volume":"24","author":"Chang","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0891-5849(94)E0137-8","article-title":"Enrichment with arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress","volume":"18","author":"Canuto","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1042\/bj3570811","article-title":"Increase in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cells","volume":"357","author":"Canuto","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib49","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.freeradbiomed.2006.01.020","article-title":"Arachidonic acid suppresses growth of human lung tumor A549 cells through down-regulation of ALDH3A1 expression","volume":"40","author":"Muzio","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4615-5871-2_14","article-title":"In hepatoma cell lines restored lipid peroxidation affects cell viability inversely to aldehyde metabolizing enzyme activity","volume":"414","author":"Canuto","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib51","doi-asserted-by":"crossref","first-page":"296146","DOI":"10.1155\/2015\/296146","article-title":"Generation of adducts of 4-hydroxy-2-nonenal with heat shock 60 kDa Protein 1 in human promyelocytic HL-60 and Monocytic THP-1 cell lines","volume":"2015","author":"Arcaro","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jnutbio.2009.06.005","article-title":"4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity","volume":"21","author":"Pizzimenti","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11745-012-3734-6","article-title":"CLA reduces inflammatory mediators from A427 human lung cancer cells and A427 conditioned medium promotes differentiation of C2C12 murine muscle cells","volume":"48","author":"Oraldi","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cbi.2006.12.014","article-title":"Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs","volume":"165","author":"Trombetta","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib55","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.freeradbiomed.2007.02.009","article-title":"4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells","volume":"42","author":"Cerbone","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00441-015-2120-0","article-title":"High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPAR\u03b1 and PPAR\u03b2\/\u03b4","volume":"361","author":"Manea","year":"2015","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.freeradbiomed.2016.07.031_bib57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916303732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916303732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:34:46Z","timestamp":1760204086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584916303732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":57,"alternative-id":["S0891584916303732"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.07.031","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}